These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36404709)

  • 1. Loss of pulsatility with continuous-flow left ventricular assist devices and the significance of the arterial endothelium in von-Willebrand factor production and degradation.
    Giridharan GA; Berg IC; Ismail E; Nguyen KT; Hecking J; Kirklin JK; Cheng X; Sethu P
    Artif Organs; 2023 Apr; 47(4):640-648. PubMed ID: 36404709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pulsatility on shear-induced extensional behavior of Von Willebrand factor.
    Wang Y; Nguyen KT; Ismail E; Donoghue L; Giridharan GA; Sethu P; Cheng X
    Artif Organs; 2022 May; 46(5):887-898. PubMed ID: 34866200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.
    Vincent F; Rauch A; Loobuyck V; Robin E; Nix C; Vincentelli A; Smadja DM; Leprince P; Amour J; Lemesle G; Spillemaeker H; Debry N; Latremouille C; Jansen P; Capel A; Moussa M; Rousse N; Schurtz G; Delhaye C; Paris C; Jeanpierre E; Dupont A; Corseaux D; Rosa M; Sottejeau Y; Barth S; Mourran C; Gomane V; Coisne A; Richardson M; Caron C; Preda C; Ung A; Carpentier A; Hubert T; Denis C; Staels B; Lenting PJ; Van Belle E; Susen S
    J Am Coll Cardiol; 2018 May; 71(19):2106-2118. PubMed ID: 29747831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
    Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
    ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
    JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
    Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
    Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
    Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.
    Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
    Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
    Bartoli CR; Kang J; Motomura T
    J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress and Exposure Time on von Willebrand Factor Degradation.
    Jhun CS; Siedlecki C; Xu L; Lukic B; Newswanger R; Yeager E; Reibson J; Cysyk J; Weiss W; Rosenberg G
    Artif Organs; 2019 Feb; 43(2):199-206. PubMed ID: 30374981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI.
    Lukito P; Wong A; Jing J; Arthur JF; Marasco SF; Murphy DA; Bergin PJ; Shaw JA; Collecutt M; Andrews RK; Gardiner EE; Davis AK
    J Thromb Haemost; 2016 Nov; 14(11):2253-2260. PubMed ID: 27601054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
    Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand factor deficiency is reduced in HeartMate 3 patients†.
    Klaeske K; Dieterlen MT; Scholz U; Lehmann S; Garbade J; Fischer J; Jawad K; Borger MA; Meyer A
    Eur J Cardiothorac Surg; 2019 Sep; 56(3):444-450. PubMed ID: 30815698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
    Deconinck SJ; Nix C; Barth S; Bennek-Schöpping E; Rauch A; Schelpe AS; Roose E; Feys HB; Pareyn I; Vandenbulcke A; Muia J; Vandenbriele C; Susen S; Meyns B; Tersteeg C; Jacobs S; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2022 Dec; 20(12):2797-2809. PubMed ID: 36128768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices.
    Geisen U; Brehm K; Trummer G; Berchtold-Herz M; Heilmann C; Beyersdorf F; Schelling J; Schlagenhauf A; Zieger B
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.